{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:46:23Z","timestamp":1771724783625,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.contraception.2009.01.009","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T04:51:54Z","timestamp":1237351914000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone"],"prefix":"10.1016","volume":"80","author":[{"given":"Monika","family":"Sch\u00f6ller-Gy\u00fcre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas N.","family":"Kakuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Woodfall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Aharchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kati","family":"Vandermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.W.","family":"Hoetelmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.01.009_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/jwh.2006.0204","article-title":"Contraceptive use among U.S. women with HIV","volume":"16","author":"Massad","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.contraception.2009.01.009_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/QAI.0b013e31813e5fa5","article-title":"Pregnancy prevention practices among women with multiple partners in an HIV prevention trial","volume":"46","author":"Macqueen","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2009.01.009_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/sti.2003.008441","article-title":"Contraception choice for HIV positive women","volume":"80","author":"Mitchell","year":"2004","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.contraception.2009.01.009_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","article-title":"Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug","volume":"46","author":"Zhang","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2009.01.009_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0022-4731(79)90160-2","article-title":"Intestinal absorption of synthetic steroids","volume":"11","author":"Reed","year":"1979","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2009.01.009_bib7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/dmd.104.000182","article-title":"The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 alpha-ethinylestradiol","volume":"32","author":"Wang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.contraception.2009.01.009_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2125.2000.00271.x","article-title":"Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1\u2032-hydroxylation","volume":"50","author":"Palovaara","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2009.01.009_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-2125.2003.01868.x","article-title":"The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects","volume":"56","author":"Palovaara","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2009.01.009_bib10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/009127009803801109","article-title":"Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone","volume":"38","author":"LeBel","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2009.01.009_bib11","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1128\/AAC.48.12.4680-4686.2004","article-title":"TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1","volume":"48","author":"Andries","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.contraception.2009.01.009_bib12","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.1128\/JVI.79.20.12773-12782.2005","article-title":"TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments","volume":"79","author":"Vingerhoets","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.contraception.2009.01.009_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(07)61047-2","article-title":"Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial","volume":"370","author":"Madruga","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.01.009_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(07)61048-4","article-title":"Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial","volume":"370","author":"Lazzarin","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.01.009_bib15","article-title":"Pooled 48-week analysis of DUET-1 and DUET-2: durable efficacy and safety results of etravirine (ETR; TMC125) in treatment-experienced HIV-infected patients","author":"Trottier","year":"2008"},{"key":"10.1016\/j.contraception.2009.01.009_bib16","article-title":"TMC125 in combination with other medications: summary of drug-drug interactions","author":"Kakuda","year":"2006"},{"key":"10.1016\/j.contraception.2009.01.009_bib17","article-title":"No clinically relevant effect of etravirine (ETR;TMC125) on digoxin pharmacokinetics in HIV-negative volunteers","author":"Sch\u00f6ller-Gy\u00fcre","year":"2008"},{"key":"10.1016\/j.contraception.2009.01.009_bib18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1592\/phco.28.10.1215","article-title":"Effect of different meal compositions and fasted state on the oral bioavailability of etravirine","volume":"28","author":"Sch\u00f6ller-Gy\u00fcre","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.contraception.2009.01.009_bib19","series-title":"Sustiva Package Insert","year":"2008"},{"key":"10.1016\/j.contraception.2009.01.009_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11904-007-0020-y","article-title":"Teratogenicity risk of antiretroviral therapy in pregnancy","volume":"4","author":"Watts","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.contraception.2009.01.009_bib21","series-title":"Intelence Prescribing Information","year":"2008"},{"key":"10.1016\/j.contraception.2009.01.009_bib22","series-title":"Viramune. Package Insert","year":"2008"},{"key":"10.1016\/j.contraception.2009.01.009_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/QAD.0b013e3282fa75df","article-title":"Is there a role for etravirine in patients with nonnucleoside reverse transcriptase inhibitor resistance?","volume":"22","author":"Scott","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2009.01.009_bib24","series-title":"Ortho-Novum 1\/35 (norethindrone and ethinyl estradiol) package insert","year":"2008"},{"issue":"4","key":"10.1016\/j.contraception.2009.01.009_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2125.2008.03214.x","article-title":"A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-volunteers","volume":"66","author":"Sch\u00f6ller-Gy\u00fcre","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2009.01.009_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1345\/aph.1K681","article-title":"Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers","volume":"42","author":"Peeters","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.contraception.2009.01.009_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00042560-200204150-00007","article-title":"Pharmacokinetic interaction between nevirapine and ethinyl estradiol\/norethindrone when administered concurrently to HIV-infected women","volume":"29","author":"Mildvan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2009.01.009_bib29","article-title":"Effect of efavirenz on the pharmacokinetics of ethinyl estradiol and norgestimate in healthy female subjects","author":"Sevinsky","year":"2008"},{"key":"10.1016\/j.contraception.2009.01.009_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clpt.2004.01.003","article-title":"The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone","volume":"75","author":"Hendrix","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2009.01.009_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2009.01.009_bib32","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1128\/AAC.00526-07","article-title":"Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects","volume":"51","author":"Liu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.contraception.2009.01.009_bib33","first-page":"218","article-title":"Evaluation of interaction between fluconazole and an oral contraceptive in healthy women","volume":"98","author":"Hilbert","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.01.009_bib34","series-title":"Crixivan (indinavir sulfate) package insert","year":"2006"},{"key":"10.1016\/j.contraception.2009.01.009_bib35","series-title":"Lipitor (atorvastatin calcium) package insert","year":"2007"},{"key":"10.1016\/j.contraception.2009.01.009_bib36","unstructured":"EMEA CPMP Public assessment report: combined oral contraceptives and venous thromboembolism. Doc.Ref:EMEA\/CPMP\/2201\/01\/en\/Final 2001."},{"key":"10.1016\/j.contraception.2009.01.009_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0010-7824(98)00148-6","article-title":"Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers","volume":"59","author":"Stanczyk","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.01.009_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case\u2013control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.01.009_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(95)00137-9","article-title":"The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial","volume":"52","author":"Moutos","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.01.009_bib40","article-title":"Pharmacokinetics of etravirine are not affected by sex, age, race, use of enfuvirtide or treatment duration in HIV-infected patients","author":"Kakuda","year":"2008"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:08:58Z","timestamp":1757880538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0010782409000262"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.01.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2009.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}